Philips is a global health technology leader and one of the world's leading diagnostic imaging companies.
Philips is a global health technology company with a Diagnosis & Treatment segment generating approximately $7.6–$8.6 billion in annual revenue — encompassing diagnostic imaging, image-guided therapy, and ultrasound. The company has undergone a multi-year transformation following the Respironics sleep apnea device recall of 2021, which required billions in remediation costs and management attention. Philips's imaging portfolio spans MRI, CT, X-ray, fluoroscopy, ultrasound, and nuclear medicine — with particular strength in image-guided therapy systems used in interventional radiology and cardiology. The Spectral CT 7500 with spectral imaging capabilities and the BlueSeal helium-free MRI represent the technology leadership platforms.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and key platforms
• Latest products, programs, and AI portfolio
• M&A and partnership activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management
Table of Contents
1. Executive Summary
2. Company Overview
3. Strategic Directions
4. Financial Performance
5. SWOT Analysis
6. Technological Know-How and Key Products
7. M&A and Partnerships
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Philips — Key Financial Metrics 2023-2025
Table 2. Philips — Revenue by Modality 2023-2025
Table 3. Philips — Revenue by Geography 2023-2025
Table 4. Philips — R&D Investment 2023-2025
Table 5. Philips — SWOT Analysis
Table 6. Philips — Key Products and Platforms 2025
Table 7. Philips — M&A Activity 2020-2025
Table 8. Philips — Key Management 2025
Table 9. Philips — Strategic Priorities 2025-2030
